4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-19-000320
PRES./CHIEF SCIENTIFIC OFFICER acquired 2,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2019-03-13 | Option exercise | +2,500 | $1.50 | $3,750 | 62,724 | D |
| Derivatives | |||||||
| SNODGRASS H. RALPH PRES./CHIEF SCIENTIFIC OFFICER | 2019-03-13 | Option exercise · Stock Option (Right to Buy) | −2,500 | 0 | D | ||
Loading xslF345X03/form4-03142019_020328.xml…